<DOC>
	<DOCNO>NCT03070353</DOCNO>
	<brief_summary>A pilot study Dextran-40 infusion patient decompensated cirrhosis presenting AKI</brief_summary>
	<brief_title>Dextran , Plasma Expander , Offers New Hope Patients With Decompensated Liver Cirrhosis Acute Kidney Injury</brief_title>
	<detailed_description>A pilot study Dextran-40 infusion decompensated cirrhotic patient complicate AKI . Dextran-40Â® administer 1 g/kg/day two day . AKI reversal define serum creatinine &lt; 1.5 mg/dL . Albumin infusion give AKI reversal occur .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<criteria>Decompensated cirrhosis acute kidney injury Ager 18 year old Having chronic kidney disease , severe heart lung disease , severe sepsis Pregnant Receiving nephrotoxic agent Having history allergic Dextran</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Cirrhosis</keyword>
	<keyword>AKI</keyword>
	<keyword>Albumin</keyword>
	<keyword>Dextran</keyword>
</DOC>